STAT News

STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred.

By STAT News

1 min read
STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights